Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 31 | 2025 | 204 | 5.440 |
Why?
|
| Cognition Disorders | 32 | 2017 | 175 | 4.420 |
Why?
|
| Cognition | 36 | 2019 | 220 | 4.280 |
Why?
|
| Cognitive Dysfunction | 22 | 2025 | 165 | 4.010 |
Why?
|
| Alzheimer Disease | 31 | 2025 | 250 | 3.190 |
Why?
|
| Aged | 80 | 2025 | 956 | 2.950 |
Why?
|
| Male | 87 | 2025 | 1860 | 2.800 |
Why?
|
| Female | 86 | 2025 | 1724 | 2.800 |
Why?
|
| Brain | 18 | 2019 | 202 | 2.660 |
Why?
|
| Aged, 80 and over | 63 | 2025 | 567 | 2.590 |
Why?
|
| Humans | 90 | 2025 | 2957 | 2.440 |
Why?
|
| Longitudinal Studies | 44 | 2025 | 260 | 2.250 |
Why?
|
| Dementia | 9 | 2018 | 73 | 2.100 |
Why?
|
| Neuropsychological Tests | 28 | 2019 | 238 | 1.660 |
Why?
|
| DNA-Binding Proteins | 7 | 2019 | 69 | 1.440 |
Why?
|
| Memory, Episodic | 3 | 2019 | 22 | 1.210 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 34 | 1.100 |
Why?
|
| Cognitive Aging | 5 | 2018 | 27 | 1.030 |
Why?
|
| Disease Progression | 11 | 2019 | 99 | 0.950 |
Why?
|
| Loneliness | 6 | 2025 | 20 | 0.950 |
Why?
|
| Chicago | 17 | 2025 | 160 | 0.950 |
Why?
|
| Memory | 6 | 2016 | 48 | 0.940 |
Why?
|
| Hospitalization | 2 | 2017 | 49 | 0.900 |
Why?
|
| Follow-Up Studies | 19 | 2017 | 147 | 0.890 |
Why?
|
| Depression | 6 | 2016 | 59 | 0.880 |
Why?
|
| Apolipoprotein E4 | 11 | 2025 | 76 | 0.840 |
Why?
|
| Middle Aged | 16 | 2017 | 792 | 0.810 |
Why?
|
| Perception | 3 | 2019 | 21 | 0.770 |
Why?
|
| Personality | 3 | 2015 | 8 | 0.730 |
Why?
|
| Lewy Bodies | 4 | 2019 | 37 | 0.730 |
Why?
|
| Hippocampus | 3 | 2019 | 41 | 0.720 |
Why?
|
| Interpersonal Relations | 3 | 2014 | 12 | 0.690 |
Why?
|
| Cohort Studies | 16 | 2024 | 233 | 0.690 |
Why?
|
| Neurofibrillary Tangles | 5 | 2017 | 24 | 0.680 |
Why?
|
| Risk Factors | 24 | 2018 | 275 | 0.670 |
Why?
|
| Memory, Short-Term | 2 | 2019 | 23 | 0.610 |
Why?
|
| Health Literacy | 2 | 2017 | 15 | 0.600 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2017 | 92 | 0.600 |
Why?
|
| Geriatric Assessment | 10 | 2017 | 38 | 0.570 |
Why?
|
| Language | 2 | 2010 | 12 | 0.570 |
Why?
|
| Memory Disorders | 2 | 2017 | 33 | 0.570 |
Why?
|
| Learning | 1 | 2018 | 20 | 0.540 |
Why?
|
| Ambulatory Care | 1 | 2017 | 9 | 0.520 |
Why?
|
| Chronic Disease | 1 | 2017 | 28 | 0.520 |
Why?
|
| Amyloid beta-Peptides | 2 | 2017 | 28 | 0.500 |
Why?
|
| Agnosia | 1 | 2016 | 3 | 0.490 |
Why?
|
| Reading | 1 | 2016 | 4 | 0.480 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 16 | 0.470 |
Why?
|
| Brain Chemistry | 1 | 2016 | 11 | 0.470 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 13 | 0.470 |
Why?
|
| Urban Population | 3 | 2013 | 23 | 0.470 |
Why?
|
| Apolipoproteins E | 6 | 2017 | 34 | 0.460 |
Why?
|
| Motor Activity | 5 | 2015 | 53 | 0.440 |
Why?
|
| Activities of Daily Living | 4 | 2013 | 28 | 0.430 |
Why?
|
| Parkinsonian Disorders | 4 | 2017 | 24 | 0.420 |
Why?
|
| Autopsy | 6 | 2019 | 39 | 0.390 |
Why?
|
| Membrane Transport Proteins | 3 | 2017 | 22 | 0.380 |
Why?
|
| Age Factors | 8 | 2016 | 89 | 0.370 |
Why?
|
| Mortality | 2 | 2016 | 13 | 0.350 |
Why?
|
| Diet | 4 | 2010 | 36 | 0.350 |
Why?
|
| Risk | 9 | 2018 | 44 | 0.340 |
Why?
|
| Stroke | 3 | 2016 | 49 | 0.330 |
Why?
|
| Knowledge | 1 | 2010 | 3 | 0.330 |
Why?
|
| United States | 9 | 2018 | 243 | 0.320 |
Why?
|
| Social Isolation | 3 | 2025 | 8 | 0.320 |
Why?
|
| Stress, Psychological | 3 | 2014 | 24 | 0.300 |
Why?
|
| Sclerosis | 3 | 2019 | 25 | 0.290 |
Why?
|
| Incidence | 11 | 2025 | 110 | 0.290 |
Why?
|
| Antioxidants | 3 | 2005 | 17 | 0.280 |
Why?
|
| Educational Status | 6 | 2017 | 41 | 0.280 |
Why?
|
| Feeding Behavior | 2 | 2005 | 18 | 0.280 |
Why?
|
| Prospective Studies | 10 | 2025 | 203 | 0.270 |
Why?
|
| Proportional Hazards Models | 7 | 2017 | 51 | 0.270 |
Why?
|
| Decision Making | 2 | 2018 | 19 | 0.250 |
Why?
|
| Dietary Fats | 2 | 2006 | 14 | 0.250 |
Why?
|
| Vitamin E | 3 | 2005 | 13 | 0.250 |
Why?
|
| Independent Living | 4 | 2025 | 29 | 0.250 |
Why?
|
| Logistic Models | 6 | 2017 | 60 | 0.250 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2017 | 12 | 0.250 |
Why?
|
| Language Tests | 1 | 2006 | 3 | 0.250 |
Why?
|
| Intelligence | 1 | 2006 | 3 | 0.250 |
Why?
|
| Smell | 2 | 2016 | 7 | 0.240 |
Why?
|
| Child Abuse | 1 | 2006 | 2 | 0.240 |
Why?
|
| Personality Disorders | 1 | 2006 | 2 | 0.240 |
Why?
|
| Awareness | 2 | 2016 | 10 | 0.240 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 18 | 0.240 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 1 | 0.230 |
Why?
|
| Delusions | 1 | 2005 | 3 | 0.230 |
Why?
|
| Hallucinations | 1 | 2005 | 7 | 0.230 |
Why?
|
| Fish Products | 1 | 2005 | 2 | 0.230 |
Why?
|
| Fishes | 1 | 2005 | 2 | 0.230 |
Why?
|
| Time Factors | 5 | 2017 | 208 | 0.230 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2015 | 17 | 0.230 |
Why?
|
| Plaque, Amyloid | 3 | 2017 | 18 | 0.230 |
Why?
|
| Life | 1 | 2005 | 2 | 0.230 |
Why?
|
| Lipids | 1 | 2025 | 13 | 0.220 |
Why?
|
| Diet Surveys | 2 | 2006 | 9 | 0.220 |
Why?
|
| Severity of Illness Index | 6 | 2018 | 97 | 0.220 |
Why?
|
| Surveys and Questionnaires | 7 | 2016 | 142 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 5 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 5 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2024 | 6 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Air Pollution | 1 | 2024 | 6 | 0.220 |
Why?
|
| Genotype | 8 | 2017 | 85 | 0.210 |
Why?
|
| Sex Factors | 4 | 2016 | 72 | 0.210 |
Why?
|
| Nutrition Disorders | 1 | 2003 | 2 | 0.200 |
Why?
|
| Life Change Events | 2 | 2014 | 10 | 0.200 |
Why?
|
| Cerebral Infarction | 3 | 2015 | 18 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2016 | 34 | 0.200 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 105 | 0.190 |
Why?
|
| Disability Evaluation | 5 | 2015 | 23 | 0.190 |
Why?
|
| Vitamin A | 1 | 2002 | 2 | 0.190 |
Why?
|
| Carotenoids | 1 | 2002 | 3 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 46 | 0.180 |
Why?
|
| Adult | 3 | 2015 | 794 | 0.170 |
Why?
|
| Linear Models | 6 | 2017 | 39 | 0.160 |
Why?
|
| Comorbidity | 4 | 2018 | 49 | 0.160 |
Why?
|
| Neoplasms | 2 | 2018 | 18 | 0.160 |
Why?
|
| Neuropathology | 2 | 2017 | 16 | 0.150 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 9 | 0.150 |
Why?
|
| Disabled Persons | 2 | 2012 | 9 | 0.150 |
Why?
|
| Mental Status Schedule | 4 | 2017 | 29 | 0.150 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 4 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 16 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2018 | 25 | 0.140 |
Why?
|
| Parkinson Disease | 2 | 2017 | 65 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 9 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 9 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 45 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 6 | 0.130 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 22 | 0.130 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 34 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2016 | 27 | 0.130 |
Why?
|
| Haplotypes | 1 | 2017 | 9 | 0.130 |
Why?
|
| Literacy | 1 | 2017 | 4 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 21 | 0.130 |
Why?
|
| Alleles | 4 | 2016 | 65 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 4 | 0.130 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2017 | 11 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 44 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2016 | 10 | 0.120 |
Why?
|
| Personality Inventory | 2 | 2007 | 7 | 0.120 |
Why?
|
| Neuroticism | 1 | 2016 | 4 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 28 | 0.120 |
Why?
|
| Biostatistics | 1 | 2016 | 3 | 0.120 |
Why?
|
| Employment | 1 | 2016 | 8 | 0.120 |
Why?
|
| Brain Stem | 1 | 2016 | 5 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 2 | 0.120 |
Why?
|
| Social Adjustment | 2 | 2006 | 5 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 28 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 10 | 0.120 |
Why?
|
| HIV Infections | 1 | 2017 | 103 | 0.120 |
Why?
|
| Copper | 2 | 2024 | 11 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2015 | 7 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 4 | 0.110 |
Why?
|
| Reaction Time | 1 | 2015 | 29 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2006 | 83 | 0.110 |
Why?
|
| Empathy | 1 | 2014 | 5 | 0.110 |
Why?
|
| Mental Recall | 1 | 2014 | 14 | 0.110 |
Why?
|
| Quality of Life | 1 | 2015 | 39 | 0.110 |
Why?
|
| Models, Psychological | 2 | 2015 | 6 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2013 | 7 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2013 | 167 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2017 | 32 | 0.090 |
Why?
|
| Anomie | 1 | 2012 | 2 | 0.090 |
Why?
|
| Social Environment | 1 | 2012 | 3 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2017 | 19 | 0.090 |
Why?
|
| Social Behavior | 2 | 2009 | 8 | 0.090 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 34 | 0.080 |
Why?
|
| Heterozygote | 2 | 2025 | 48 | 0.080 |
Why?
|
| Diet, Mediterranean | 1 | 2010 | 12 | 0.080 |
Why?
|
| Population Surveillance | 2 | 2015 | 14 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2005 | 7 | 0.070 |
Why?
|
| Prognosis | 2 | 2018 | 39 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2018 | 51 | 0.060 |
Why?
|
| Latin America | 1 | 2006 | 1 | 0.060 |
Why?
|
| Wechsler Scales | 1 | 2006 | 1 | 0.060 |
Why?
|
| Lewy Body Disease | 2 | 2018 | 13 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2017 | 9 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 24 | 0.060 |
Why?
|
| Trans Fatty Acids | 1 | 2006 | 4 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2006 | 6 | 0.060 |
Why?
|
| Illinois | 2 | 2017 | 22 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2017 | 13 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 2 | 0.060 |
Why?
|
| Parenting | 1 | 2006 | 3 | 0.060 |
Why?
|
| Psychology | 1 | 2006 | 3 | 0.060 |
Why?
|
| Parents | 1 | 2006 | 6 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 46 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 6 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 12 | 0.060 |
Why?
|
| Longevity | 1 | 2005 | 2 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2005 | 7 | 0.060 |
Why?
|
| Eating | 1 | 2005 | 4 | 0.060 |
Why?
|
| Energy Intake | 1 | 2005 | 24 | 0.060 |
Why?
|
| Health Status | 1 | 2005 | 19 | 0.060 |
Why?
|
| Child | 1 | 2006 | 197 | 0.060 |
Why?
|
| Psychometrics | 1 | 2005 | 27 | 0.060 |
Why?
|
| Triglycerides | 1 | 2025 | 11 | 0.060 |
Why?
|
| Tocopherols | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cholesterol | 1 | 2025 | 18 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 9 | 0.050 |
Why?
|
| Residence Characteristics | 2 | 2015 | 18 | 0.050 |
Why?
|
| Seafood | 1 | 2003 | 6 | 0.050 |
Why?
|
| Age of Onset | 2 | 2013 | 22 | 0.050 |
Why?
|
| Animals | 1 | 2005 | 1050 | 0.050 |
Why?
|
| Psychological Tests | 1 | 2002 | 4 | 0.050 |
Why?
|
| Nutrition Assessment | 3 | 2005 | 18 | 0.040 |
Why?
|
| Prevalence | 1 | 2018 | 39 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 50 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2018 | 46 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 19 | 0.040 |
Why?
|
| Biomarkers | 1 | 2018 | 101 | 0.030 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 6 | 0.030 |
Why?
|
| Inflammation | 1 | 2018 | 31 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 5 | 0.030 |
Why?
|
| Diagnosis | 1 | 2017 | 5 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 6 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 5 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 32 | 0.030 |
Why?
|
| Arteriolosclerosis | 1 | 2016 | 4 | 0.030 |
Why?
|
| tau Proteins | 1 | 2017 | 18 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 11 | 0.030 |
Why?
|
| Brain Infarction | 1 | 2016 | 20 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 11 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 8 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 24 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 11 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 37 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 6 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 8 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 77 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 64 | 0.030 |
Why?
|
| Self Report | 1 | 2015 | 20 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 4 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 14 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 7 | 0.030 |
Why?
|
| Medicare | 1 | 2014 | 8 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 14 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2014 | 4 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 6 | 0.030 |
Why?
|
| Life Style | 1 | 2014 | 19 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2005 | 16 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 27 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 4 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 7 | 0.020 |
Why?
|
| Wine | 1 | 2010 | 2 | 0.020 |
Why?
|
| Nutrition Policy | 1 | 2010 | 3 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 13 | 0.020 |
Why?
|
| Social Support | 1 | 2009 | 7 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2006 | 5 | 0.020 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 3 | 0.010 |
Why?
|
| gamma-Tocopherol | 1 | 2005 | 3 | 0.010 |
Why?
|
| Clergy | 1 | 2005 | 4 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2003 | 3 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 4 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 4 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 6 | 0.010 |
Why?
|
| beta Carotene | 1 | 2002 | 4 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2002 | 10 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 15 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 13 | 0.010 |
Why?
|